10 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret156-3-509-2264
P%wins3317671002510057

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

9/13/21 19:27
9/10/21
BGNEHealthBioPrdBiological Products, (No DiagAmgen IncCATP50,000302.060166118,944D
8/6/18 17:22
8/2/18
BGNEHealthDrugPharmaceutical PreparationsBaker Bros. Advisors LPNYDTP627,923108.0005,8145117,225I
1/22/18 17:03
1/18/18
BGNEHealthDrugPharmaceutical PreparationsBaker Bros. Advisors LPNYDTP200,000101.0001,980284,831I
8/14/17 15:49
8/11/17
BGNEHealthDrugPharmaceutical PreparationsBaker Bros. Advisors LPNYDTP12,50071.000176083,811I
11/28/16 16:02
11/23/16
BGNEHealthDrugPharmaceutical PreparationsMalley ThomasCODP96032.00630New30D191633-11320-425
11/21/16 18:13
11/18/16
BGNEHealthDrugPharmaceutical PreparationsBaker Bros. Advisors LPNYDTP56,33632.0061,760283,653I15100-4-5-120-2-1126
2/10/16 16:32
2/8/16
BGNEHealthDrugPharmaceutical PreparationsHillhouse Capital Management, Ltd.E9TP.d00.0099,1003039,727I-9-10-343133
2/9/16 20:08
2/8/16
BGNEHealthDrugPharmaceutical PreparationsLiang HowardE9OCFO,ChieP1201.85965New65D-3-840-323
2/9/16 20:08
2/8/16
BGNEHealthDrugPharmaceutical PreparationsYuan RuirongE9OChief MeP2411.859130New130D-3-840-323
2/9/16 17:38
2/8/16
BGNEHealthDrugPharmaceutical PreparationsBaker Bros. Advisors LPNYDTP.d45,90424.0091,9134252,363I-3-840-323

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact